Year: 2021

The leading digital automotive marketplace will participate in a wide variety of speaking sessions and events from November 15-18 in Las Vegas, Nevada BUFFALO, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, is pleased to participate at Used Car Week 2021, an annual conference that unites all corners of the used-car industry, as a platinum-level sponsor and exhibitor. ACV CEO George Chamoun will provide the opening keynote address on Thursday, November 18, discussing the company’s growth since going public in March and offering a preview for what lies ahead. Additional ACV thought leaders will participate in speaking sessions and events throughout the conference. Several ACV teammates will also be honored during...

NEWPORT NEWS, Va., Nov. 12, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that four employees from across the enterprise received achievement awards during the 2021 Society of Asian Scientists and Engineers (SASE) National Conference and STEM Career Fair, the largest conference and career fair focused on science, technology, engineering and math for Asian Americans in the United States. Matthew Burris, an engineer at Newport News Shipbuilding, received the Career Achievement award. The award recognizes highly experienced, mid-career professionals who have made significant achievements in engineering and the nominee’s performance as a role model and mentor for Asian and Pacific Islanders in technology. Dennis Seran, a software engineer at Technical Solutions; Reby Vanta, an electrical mechanical...

Progranulin Levels Increase to Normal Ranges Multiple Biomarkers of Disease Showed Improvement from Baseline with AL001 Treatment, Including GFAP, a Prognostic Marker for FTD Associated with Brain Atrophy FTD-GRN Patients Showed a Slowing of Clinical Progression with AL001 Treatment Relative to GENFI2 Matched Control Cohort Data from Phase 2 Study Presented at Clinical Trials of Alzheimer Disease Conference; Management to Host Webcast to Review Results Today at 4:00 p.m. ET BOSTON, Nov. 12, 2021 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, presented encouraging results from the company’s INFRONT-2 Phase 2 clinical trial of AL001 at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) conference taking place virtually and in Boston. AL001 is a potential...

Alpha Esports Tech and the New Jersey Devils resumes partnership to run PlayStation and Xbox NHL 22 Tournaments VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) — Alpha Esports Tech Inc. (CSE: ALPA) (FSE:(9HN), (OTC PINK: APETF) (“Alpha” or the “Company”), a technology company that focuses on emerging markets in esports, mobile gaming, commerce, blockchain, and high growth opportunities, is proud to announce that Alpha and the New Jersey Devils (“Devils”) are continuing their previously announced partnership by running two separate NHL 22 tournaments on November 14th, 2021. Using Alpha’s gaming platform, GamerzArena, The Devils and Alpha will run a PlayStation 5 tournament and an Xbox Series X/S tournament. The tournament will allow users from New Jersey, New York, Pennsylvania, and Connecticut to compete on GamerzArena....

Minsk, Belarus, Nov. 12, 2021 (GLOBE NEWSWIRE) — Protect Pharmaceutical Corp. “OTC:(PRTT)” Aetsoft, a leading digital solutions provider, and Protect Pharmaceutical Corp (PRTT), an exploration-stage company, are pleased to announce a partnership agreement. Per the agreement, the two companies will combine synergies in technology, development, technical talent, and R&D product areas, producing “win-win” for both companies. For many years, Aetsoft has been on the leading edge of innovative technologies, devoting its deep technical expertise and strong R&D practices to deliver top-notch products to the global market. The company is the world’s first provider of such sought-after products as the Digital Health Passport designed to protect enterprises and countries against the world-shaking COVID-19 pandemic. Aetsoft has also...

NEW YORK, Nov. 12, 2021 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will provide a corporate overview at the Stifel 2021 Virtual Healthcare Conference, taking place November 15-17, 2021. Stifel 2021 Virtual Healthcare Conference PresentationDate: Wednesday, November 17th, 2021Time:  2:00pm Eastern TimeWebcast:  The presentation will be available via webcast and can be accessed at the Investor Relations section of the Company’s website, located at www.immunovant.comAbout Immunovant, Inc.  Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases. Immunovant is...

Contacts Media Contact Investor RelationsAmsterdam +31 20 721 4133 Brussels +32 2 620 15 50 +33 1 70 48 24 27Dublin +353 87 361 2380 Lisbon +351 210 600 614  Milan +39 02 72 42 62 12 Oslo +47 41 69 59 10  Paris +33 1 70 48 24 45      Euronext announces its financial calendar for 2022 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 12 November 2021 – Euronext, the leading pan-European exchange in the Eurozone, today announced its financial calendar for 2022, set as follows:Full-year 2021 results:Release on Thursday 10 February 2022, after market closing Analysts conference on Friday 11 February 2022, at 9.00am (CET) Quiet period from 21 January to 10 February 2022Q1 2022 results:Release on Tuesday 17 May 2022, after market closing Analysts conference on Wednesday 18 May 2022, at 9.00am (CEST) Quiet...

MANAGEMENT REPORT CEO summary The third quarter of this year has been very dynamic, with amazing results in sales activities and exceeding expectations when signing presale agreements, but it has been also challenging in development activities due to changes in the construction market. Real estate development We have continued construction of Kindrali Houses and Kalaranna projects and are preparing project documentation for the following development phases in Tallinn. In September we started handing over apartments in two first buildings of Kalaranna project, where completion of eight buildings with the total of 240 apartments will be achieved step by step in four phases. Today we have reservations or presales concluded for all business premises and for 94% of apartments. This year we started construction of the new project Kindrali Houses...

MANAGEMENT REPORT CEO summary The third quarter of this year has been very dynamic, with amazing results in sales activities and exceeding expectations when signing presale agreements, but it has been also challenging in development activities due to changes in the construction market. Real estate development We have continued construction of Kindrali Houses and Kalaranna projects and are preparing project documentation for the following development phases in Tallinn. In September we started handing over apartments in two first buildings of Kalaranna project, where completion of eight buildings with the total of 240 apartments will be achieved step by step in four phases. Today we have reservations or presales concluded for all business premises and for 94% of apartments. This year we started construction of the new project Kindrali Houses...